EA200201039A1 - ANTI-VIRUS AND ANTIBACTERIAL PHARMACEUTICALS AND ITS APPLICATION FOR THE TREATMENT OF INFECTIOUS DISEASES - Google Patents
ANTI-VIRUS AND ANTIBACTERIAL PHARMACEUTICALS AND ITS APPLICATION FOR THE TREATMENT OF INFECTIOUS DISEASESInfo
- Publication number
- EA200201039A1 EA200201039A1 EA200201039A EA200201039A EA200201039A1 EA 200201039 A1 EA200201039 A1 EA 200201039A1 EA 200201039 A EA200201039 A EA 200201039A EA 200201039 A EA200201039 A EA 200201039A EA 200201039 A1 EA200201039 A1 EA 200201039A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- infectious diseases
- treatment
- diseases
- oligo
- polysaccharides
- Prior art date
Links
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Изобретение относится к медицине, конкретно к фармацевтическим антивирусным и антибактериальным препаратам, а также способу их применения для лечения инфекционных заболеваний. Задачей изобретения является создание препарата, который эффективен в отношении ДНК и РНК содержащих вирусов млекопитающих, включая человека, и может быть использован для лечения инфекционных заболеваний вирусного и бактериального характера. Такими болезнями являются СПИД, простой герпес, энцефаломиокардит и др. Сущность изобретения состоит в том, что фармацевтический препарат помимо иода, иодида калия или натрия, хлорида натрия, хлорида лития, синтетического водорастворимого полимера, моно-, олиго- и полисахаридов и воды дополнительно содержит галогенпроизводные природных соединений, а именно галогенпроизводные моно-, олиго- и полисахаридов. Препарат имеет низкую токсичность и является эффективным средством для лечения СПИДа и сопутствующих оппортунистических болезней.Международная заявка была опубликована вместе с отчетом о международном поиске.The invention relates to medicine, specifically to pharmaceutical antiviral and antibacterial drugs, as well as the method of their use for the treatment of infectious diseases. The objective of the invention is the creation of a drug that is effective against DNA and RNA of mammalian viruses, including humans, and can be used to treat infectious diseases of a viral and bacterial nature. Such diseases are AIDS, herpes simplex, encephalomyocarditis, etc. The essence of the invention is that in addition to iodine, potassium or sodium iodide, sodium chloride, lithium chloride, a synthetic water-soluble polymer, mono-, oligo- and polysaccharides and water, the pharmaceutical preparation additionally contains halogen derivatives of natural compounds, namely halogen derivatives of mono-, oligo- and polysaccharides. The drug has low toxicity and is an effective treatment for AIDS and related opportunistic diseases. The international application was published together with an international search report.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AM20000032A AM949A2 (en) | 2000-04-17 | 2000-04-17 | |
PCT/AM2000/000002 WO2001078751A1 (en) | 2000-04-17 | 2000-11-24 | Antiviral and antibacterial pharmaceutical preparation 'armenicum' and its use for treatment of infectious diseases |
Publications (2)
Publication Number | Publication Date |
---|---|
EA200201039A1 true EA200201039A1 (en) | 2003-02-27 |
EA004203B1 EA004203B1 (en) | 2004-02-26 |
Family
ID=3460604
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200201039A EA004203B1 (en) | 2000-04-17 | 2000-11-24 | Antiviral and antibacterial pharmaceutical preparation "armenicum" and the use thereof for treatment of infectious diseases |
Country Status (4)
Country | Link |
---|---|
AM (1) | AM949A2 (en) |
AP (1) | AP2002002644A0 (en) |
AU (1) | AU2001218422A1 (en) |
EA (1) | EA004203B1 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI2722053T1 (en) | 2010-12-30 | 2018-02-28 | Aktsionernoye Obshchestvo "Nauchnyi Tsentr Protivoninfektsionnyh Preparatov" | Antibacterial agent for treating infectious diseases of bacterial origin |
WO2016015691A1 (en) | 2014-07-30 | 2016-02-04 | Albert SARKESSYAN | A pharmaceutical composition having antibacterial and virucidal effects |
-
2000
- 2000-04-17 AM AM20000032A patent/AM949A2/xx unknown
- 2000-11-24 AU AU2001218422A patent/AU2001218422A1/en not_active Abandoned
- 2000-11-24 AP APAP/P/2002/002644A patent/AP2002002644A0/en unknown
- 2000-11-24 EA EA200201039A patent/EA004203B1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AM949A2 (en) | 2001-06-10 |
AP2002002644A0 (en) | 2002-12-31 |
AU2001218422A1 (en) | 2001-10-30 |
EA004203B1 (en) | 2004-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69635871T2 (en) | Methods and compositions for the selective modification of nucleic acids | |
ATE500808T1 (en) | ONCOLYTIC VIRUS THERAPY | |
DE69419244D1 (en) | COMPOSITIONS AND METHODS FOR THE USE OF REACTIVE ANTIVIRAL POLYMERS | |
BR9810745A (en) | Benzimidazole derivatives | |
IE862276L (en) | PREVENTION AND TREATMENT OF AIDS WITH dsRNA | |
BG103786A (en) | Antimicrobial prevention and treatment of human immunedeficiency virus and other infectious diseases | |
EA199800893A1 (en) | ANTIMICROBIAL TREATMENT OF DISEASES CAUSED BY VIRUS OF JUST HERPES AND OTHER INFECTIONS | |
EA199700215A1 (en) | PROTECTION AGAINST VIRAL INFECTIONS THROUGH COLONIZATION OF MUSCULAR SHELLS GENETICALLY MODIFIED BACTERIA | |
EA200100302A1 (en) | METHODS AND COMPOSITIONS FOR PROTECTIVE AND THERAPEUTIC GENETIC IMMUNIZATION | |
CY1106926T1 (en) | Gene coding for Heliomycin and its use | |
Abu-Galiyun et al. | Antiviral bioactivity of renewable polysaccharides against Varicella Zoster | |
EA199800526A1 (en) | DERIVATIVES OF BENZIMIDAZOLE AND THEIR APPLICATION FOR THE TREATMENT OF VIRAL INFECTIONS | |
EA200100076A1 (en) | MEDICAL PREPARATION OF VIRULICIDE ACTION | |
EA200201039A1 (en) | ANTI-VIRUS AND ANTIBACTERIAL PHARMACEUTICALS AND ITS APPLICATION FOR THE TREATMENT OF INFECTIOUS DISEASES | |
Peter et al. | Potential pathway that could treat Coronaviruses (COVID-19) | |
BR0209251A (en) | Foot-and-mouth disease virus vaccine | |
EP0188590A1 (en) | Therapeutic preparations for treatment of certain viral and other diseases and the preparation of the same | |
AR220091A1 (en) | METHOD TO DISINFECT A PLACE EXPOSED TO THE ATTACK OF FUNGI, BACTERIA OR VIRUSES, WITH THE EXCLUSION OF ALL THERAPEUTIC APPLICATION IN HUMAN AND VETERINARY MEDICINE AND COMPOSITIONS, DISINFECTING INDUSTRIAL CHEMICALS AND COMPOUNDS | |
EA201300487A1 (en) | MODIFIED PEPTIDES WITH ANTI-VIRUS PROPERTIES AND METHOD OF OBTAINING THEM | |
DE69230491D1 (en) | TRANSFORMED CELLS FOR THE PREVENTION OR TREATMENT OF VIRUS-INDUCED DISEASES, PARTICULARLY PATHOGENIC RETROVIRUS | |
EA200200383A1 (en) | CONTAINING CYCLESONIDE AQUEOUS PHARMACEUTICAL COMPOSITION | |
EA200401303A1 (en) | MEDICINES CONTAINING STEROIDS AND NEW ANTICHOLINERGIC MEANS | |
Sethi | Activity of Turbinaria ornata (turner) J. Agade against blue tongue virus (Btv) | |
PT859613E (en) | UTILIZATION OF FLUPIRTIN FOR PROPHYLAXIS AND THE TREATMENT OF DISEASES ASSOCIATED WITH AN ALTERATION OF THE HEMATOPOIETIC CELL SYSTEM | |
RU94016333A (en) | DRUG FOR THE TREATMENT OF VIRAL DISEASES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AZ KZ KG MD TJ TM |
|
MM4A | Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s) |
Designated state(s): AM BY RU |